Krka, d.d., a prominent pharmaceutical company headquartered in Slovenia (SI), has established itself as a leader in the global healthcare industry since its founding in 1946. With a strong presence in Europe and beyond, Krka focuses on the development, production, and marketing of prescription pharmaceuticals, over-the-counter products, and animal health medications. Renowned for its commitment to quality and innovation, Krka offers a diverse range of products, including generic medicines and proprietary brands, which are distinguished by their efficacy and affordability. The company has achieved significant milestones, including numerous awards for its research and development efforts, solidifying its position in the competitive pharmaceutical landscape. With a robust market presence and a dedication to sustainability, Krka continues to contribute to the advancement of healthcare worldwide.
How does Krka's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Krka's score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Krka reported total carbon emissions of approximately 137,839,000 kg CO2e, comprising about 79,880,000 kg CO2e from Scope 1 and about 57,059,000 kg CO2e from Scope 2. This marked a significant increase in emissions compared to previous years, with 2021 emissions at approximately 137,017,000 kg CO2e (Scope 1: 79,800,000 kg CO2e; Scope 2: 63,672,000 kg CO2e) and 2020 emissions at about 209,542,000 kg CO2e (Scope 1: 143,292,000 kg CO2e; Scope 2: 66,225,000 kg CO2e). Despite the fluctuations in emissions, Krka has not publicly disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. The company has not committed to Science-Based Targets Initiative (SBTi) reduction targets or other formal climate pledges. As a result, their climate commitments remain vague, with no clear roadmap for future emissions reductions. Overall, Krka's emissions data highlights the need for enhanced climate strategies to address their carbon footprint effectively.
Access structured emissions data, company-specific emission factors, and source documents
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|---|
Scope 1 | 33,603,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
Scope 2 | 43,761,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Krka is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.